title: Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting.
authors.affiliation: Division of Immunology, Infection and Inflammation, Centre for Rheumatic Diseases, University of Glasgow, Glasgow, Scotland, UK.
authors.forename: E J R
authors.initials: EJ
authors.lastname: Anderson
authors.forename: M A
authors.initials: MA
authors.lastname: McGrath
authors.forename: T
authors.initials: T
authors.lastname: Thalhamer
authors.forename: I B
authors.initials: IB
authors.lastname: McInnes
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy; D003424:Crohn Disease / Q000276:immunology / Q000628:therapy; D006801:Humans; D007154:Immune System Diseases / Q000276:immunology / Q000628:therapy*; D018664:Interleukin-12 / Q000037:antagonists & inhibitors* / Q000276:immunology*; D019409:Interleukin-15 / Q000276:immunology; D020381:Interleukin-17 / Q000276:immunology; D020382:Interleukin-18 / Q000276:immunology; D007378:Interleukins / Q000037:antagonists & inhibitors* / Q000276:immunology*; D051379:Mice; D011565:Psoriasis / Q000276:immunology / Q000628:therapy
chemical_list: D019409:Interleukin-15; D020381:Interleukin-17; D020382:Interleukin-18; D007378:Interleukins; D018664:Interleukin-12